May 22, 2024 · Form 4 insider transaction
LYONS GARY A bought 2,982 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Option vests in 12 monthly installments beginning June 22, 2024.